STOK logo

Stoke Therapeutics (STOK)

Profile

Full Name

Stoke Therapeutics, Inc.

Ticker Symbol

STOK

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 19, 2019

Indexes

Not included

Website

http://www.stoketherapeutics.com

Employees

128

Key Details

Price

$7.69(+1.72%)

Market cap

$415.86M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$36.55M(+316.34% YoY)

Annual EPS

-$1.65(+30.67% YoY)

PE ratio

-

Next earnings date

May 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$7.69
STOK price is $7.69

30-Day Relative Volume

0.45
STOK 30-day relative volume is 0.45

Price Performance

Price Most recent change

+1.72%
STOK price was up +1.72% on Apr 17, 2025

Price YTD change

-30.28%
STOK price is down -30.28% since January 1st

Price 1-year change

-34.39%
STOK price is down -34.39% year-on-year

Price 3-year change

-62.19%
STOK price is down -62.19% over the past 3 years

Price Range

Price All-time high

$71.58
STOK price is currently -89.26% below its historical high of $71.58

Price 3-year low

$3.35
STOK price is currently +129.55% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$415.86M
STOK market capitalization is $415.86 million

Market cap 3-year change

-47.77%
STOK market capitalization is down -47.77% over the past 3 years

Market cap All-time high

$2.55B
STOK market capitalization is currently -83.71% below its historical high of $2.55 billion

Market cap sector rank

67.08%
STOK market capitalization is higher than 67.08% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+3.76%
STOK shares outstanding is up +3.76% year-on-year

Shares Outstanding 3-Year Change

+38.15%
STOK shares outstanding is up +38.15% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.28
STOK beta is 1.28

200-day SMA

$11.63
STOK price is currently -33.87% below its 200-day simple moving average

50-day SMA

$8.17
STOK price is currently -5.93% below its 50-day simple moving average

RSI

53.56
STOK 14-day relative strength index is 53.56

Volume

0.45
STOK 30-day relative volume is 0.45

ATR

$0.60
STOK average true range is $0.60

10-day Historical Volatility

76.39%
STOK 10-day historical volatility is 76.39%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$36.55M
STOK annual revenue is $36.55 million

Revenue Analysts estimate

$83.56M
STOK annual revenue is currently -56.25% lower than the consensus analysts' forecast

Revenue 1-year change

+316.34%
STOK annual revenue is up +316.34% year-on-year

Revenue Sector rank

42.83%
STOK annual revenue is higher than 42.83% of companies in Healthcare sector

EPS

EPS

-$1.65
STOK annual earnings per share is -$1.65

EPS Analysts estimate

-$1.35
STOK annual earnings per share is currently +22.63% higher than the consensus analysts' forecast

EPS 1-year change

+30.67%
STOK annual earnings per share is up +30.67% year-on-year

EPS Sector rank

42.5%
STOK annual earnings per share is higher than 42.5% of companies in Healthcare sector

Profit

Gross profit

-
STOK annual gross profit value is unknown

Gross margin

-
STOK annual gross profit margin value is unknown

Operating profit

-$101.37M
STOK annual operating income is -$101.37 million

Operating margin

-277.31%
STOK annual operating profit margin is -277.31%

Net income

-$88.98M
STOK annual net profit is -$88.98 million

Net margin

-243.42%
STOK annual net profit margin is -243.42%

Expenses

Total expenses

$137.93M
STOK annual total expenses is $137.93 million

Operating expenses

$137.93M
STOK annual total operating expenses is $137.93 million

Cost of goods sold

-
STOK annual cost of goods sold value is unknown

Selling, general & administrative expenses

$48.79M
STOK annual SGA is $48.79 million

Depreciation and amortization

$2.18M
STOK annual depreciation & amortization is $2.18 million

Interest expense

-
STOK annual interest expense value is unknown

Income tax

-
STOK annual income tax value is unknown

EBIT & EBITDA

EBIT

-$101.37M
STOK annual earnings before interest & taxes is -$101.37 million

EBITDA

-$99.19M
STOK annual EBITDA is -$99.19 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$271.56M
STOK annual total assets is $271.56 million

Non current assets

$38.80M
STOK annual long term assets is $38.80 million

Current assets

$232.76M
STOK annual total current assets is $232.76 million

Cash and cash equivalents

$127.98M
STOK annual cash & cash equivalents is $127.98 million

Accounts receivable

-
STOK annual accounts receivable value is unknown

Inventory

-
STOK annual inventory value is unknown

Liabilities

Total liabilities

$42.53M
STOK annual total liabilities is $42.53 million

Long term liabilities

$2.48M
STOK annual total long term liabilities is $2.48 million

Current liabilities

$40.06M
STOK annual total current liabilities is $40.06 million

Accounts payable

$2.50M
STOK annual accounts payable is $2.50 million

Debt

Total debt

$2.32M
STOK annual total debt is $2.32 million

Total debt 1-year change

+12.61%
STOK annual total debt is up +12.61% year-on-year

Long term debt

-
STOK annual long term debt value is unknown

Short term debt

$2.32M
STOK annual short term debt is $2.32 million

Equity & Capital

Shareholders equity

$229.02M
STOK annual stockholders equity is $229.02 million

Book value

$229.02M
STOK annual book value is $229.02 million

Retained earnings

-$490.83M
STOK annual retained earnings is -$490.83 million

Working capital

$192.70M
STOK annual working capital is $192.70 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$86.85M
STOK annual cash flow from operations is -$86.85 million

Cash from operations 1-year change

-7.13%
STOK annual cash flow from operations is down -7.13% year-on-year

Cash from investing

-$107.47M
STOK annual cash flow from investing activities is -$107.47 million

Cash from investing 1-year change

-201.44%
STOK annual cash flow from investing activities is down -201.44% year-on-year

Cash from financing

$131.09M
STOK annual cash flow from financing activities is $131.09 million

Cash from financing 1-year change

+147.31%
STOK annual cash flow from financing activities is up +147.31% year-on-year

CAPEX

CAPEX

$203.00K
STOK annual capital expenditures is $203.00 thousand

CAPEX 1-year change

-87.44%
STOK annual capital expenditures is down -87.44% year-on-year

Free Cash Flow

Free cash flow

-$87.05M
STOK annual free cash flow is -$87.05 million

Free cash flow 1-year change

-5.29%
STOK annual free cash flow is down -5.29% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
STOK annual gross profit margin value is unknown

Operating margin

-277.31%
STOK annual operating profit margin is -277.31%

Net margin

-243.42%
STOK annual net profit margin is -243.42%

ROA & ROE

ROA

-35.60%
STOK annual return on assets is -35.60%

ROE

-45.80%
STOK annual return on equity is -45.80%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
STOK price to earnings ratio value is unknown

PE ratio Sector rank

-
STOK price to earnings ratio is unknown

PB Ratio

PB ratio

1.82
STOK price to book ratio is 1.82

PB ratio Sector rank

60.43%
STOK price to book ratio is higher than 60.43% of companies in Healthcare sector

PS Ratio

PS ratio

11.38
STOK price to sales ratio is 11.38

PS ratio Sector rank

80.49%
STOK price to sales ratio is higher than 80.49% of companies in Healthcare sector

Enterprise value

Enterprise value

$290.20M
STOK enterprise value is $290.20 million

Enterprise value Sector rank

62.56%
STOK enterprise value is higher than 62.56% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-2.93
STOK EV/EBITDA is -2.93

EV/EBITDA Sector rank

26.2%
STOK EV/EBITDA is higher than 26.2% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

5.81
STOK annual current ratio is 5.81

Quick ratio

-
STOK annual quick ratio value is unknown

Leverage

Debt to equity

0.00
STOK annual debt to equity ratio is 0.00

Interest coverage ratio

-
STOK annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
STOK piotroski f-score value is unknown

Altman Z-Score

3.09
STOK altman z-score is 3.09

Analyst ratings

Recent major analysts updates

Apr 9, 25 Needham
Buy
Mar 19, 25 HC Wainwright & Co.
Buy
Mar 19, 25 Chardan Capital
Buy
Mar 18, 25 Needham
Buy
Feb 19, 25 Chardan Capital
Buy
Feb 18, 25 Needham
Buy
Feb 18, 25 HC Wainwright & Co.
Buy
Jan 8, 25 Needham
Buy
Jan 8, 25 HC Wainwright & Co.
Buy
Dec 20, 24 Chardan Capital
Buy

Institutional Ownership

Similar stocks

TRML logo
Tourmaline Bio (TRML)
PGEN logo
Precigen (PGEN)
VERV logo
Verve Therapeutics (VERV)
ABVX logo
ABIVAX SA (ABVX)
TBPH logo
Theravance Biopharma (TBPH)
MGTX logo
MeiraGTx Holdings (MGTX)
SNDA logo
Sonida Senior Living (SNDA)
TMCI logo
Treace Medical Concepts (TMCI)
SIGA logo
SIGA Technologies (SIGA)
  • What is the ticker symbol for Stoke Therapeutics?
  • Does Stoke Therapeutics pay dividends?
  • What sector is Stoke Therapeutics in?
  • What industry is Stoke Therapeutics in?
  • What country is Stoke Therapeutics based in?
  • When did Stoke Therapeutics go public?
  • Is Stoke Therapeutics in the S&P 500?
  • Is Stoke Therapeutics in the NASDAQ 100?
  • Is Stoke Therapeutics in the Dow Jones?
  • When was Stoke Therapeutics's last earnings report?
  • When does Stoke Therapeutics report earnings?
  • Should I buy Stoke Therapeutics stock now?

What is the ticker symbol for Stoke Therapeutics?

The ticker symbol for Stoke Therapeutics is NASDAQ:STOK

Does Stoke Therapeutics pay dividends?

No, Stoke Therapeutics does not pay dividends

What sector is Stoke Therapeutics in?

Stoke Therapeutics is in the Healthcare sector

What industry is Stoke Therapeutics in?

Stoke Therapeutics is in the Biotechnology industry

What country is Stoke Therapeutics based in?

Stoke Therapeutics is headquartered in United States

When did Stoke Therapeutics go public?

Stoke Therapeutics's initial public offering (IPO) was on June 19, 2019

Is Stoke Therapeutics in the S&P 500?

No, Stoke Therapeutics is not included in the S&P 500 index

Is Stoke Therapeutics in the NASDAQ 100?

No, Stoke Therapeutics is not included in the NASDAQ 100 index

Is Stoke Therapeutics in the Dow Jones?

No, Stoke Therapeutics is not included in the Dow Jones index

When was Stoke Therapeutics's last earnings report?

Stoke Therapeutics's most recent earnings report was on Mar 18, 2025

When does Stoke Therapeutics report earnings?

The next expected earnings date for Stoke Therapeutics is May 6, 2025

Should I buy Stoke Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page